Global Monogenic Disease Testing Market Research Report 2026(Status and Outlook)

June 2026 | 86 pages | ID: G6BEDE425AABEN
Bosson Research

Abstracts

The global Monogenic Disease Testing market size was estimated at USD 4950.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 11.00% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Monogenic Disease Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Monogenic Disease Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Monogenic Disease Testing market.

Global Monogenic Disease Testing Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• Celera Support Services
• Abbott
• ELITech Group
• Auto Genomics
• PerkinElmer
• Bio-Rad Laboratories

Market Segmentation (by Type)

• Carrier Testing
• Diagnostic Testing
• New-Born Screening
• Predictive and Pre-Symptomatic Testing
• Prenatal Testing

Market Segmentation (by Application)

• Hospitals
• Clinics
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Monogenic Disease Testing Market

Overview of the regional outlook of the Monogenic Disease Testing Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monogenic Disease Testing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Monogenic Disease Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Monogenic Disease Testing
1.2 Key Market Segments
  1.2.1 Monogenic Disease Testing Segment by Type
  1.2.2 Monogenic Disease Testing Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 MONOGENIC DISEASE TESTING MARKET OVERVIEW

2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 MONOGENIC DISEASE TESTING MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Monogenic Disease Testing Product Life Cycle
3.3 Global Monogenic Disease Testing Revenue Market Share by Company (2020-2025)
3.4 Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Monogenic Disease Testing Market Competitive Situation and Trends
  3.6.1 Monogenic Disease Testing Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Monogenic Disease Testing Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 MONOGENIC DISEASE TESTING VALUE CHAIN ANALYSIS

4.1 Monogenic Disease Testing Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MONOGENIC DISEASE TESTING MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Monogenic Disease Testing Market Porter's Five Forces Analysis

6 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monogenic Disease Testing Market by Type (2020-2025)
6.3 Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)

7 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monogenic Disease Testing Market Size (M USD) by Application (2020-2025)
7.3 Global Monogenic Disease Testing Market Size Growth Rate by Application (2021-2025)

8 MONOGENIC DISEASE TESTING MARKET SEGMENTATION BY REGION

8.1 Global Monogenic Disease Testing Market Size by Region
  8.1.1 Global Monogenic Disease Testing Market Size by Region
  8.1.2 Global Monogenic Disease Testing Market Size Market Share by Region
8.2 North America
  8.2.1 North America Monogenic Disease Testing Market Size by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Monogenic Disease Testing Market Size by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Spain
8.4 Asia Pacific
  8.4.1 Asia Pacific Monogenic Disease Testing Market Size by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Monogenic Disease Testing Market Size by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Monogenic Disease Testing Market Size by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 Celera Support Services
  9.1.1 Celera Support Services Basic Information
  9.1.2 Celera Support Services Monogenic Disease Testing Product Overview
  9.1.3 Celera Support Services Monogenic Disease Testing Product Market Performance
  9.1.4 Celera Support Services SWOT Analysis
  9.1.5 Celera Support Services Business Overview
  9.1.6 Celera Support Services Recent Developments
9.2 Abbott
  9.2.1 Abbott Basic Information
  9.2.2 Abbott Monogenic Disease Testing Product Overview
  9.2.3 Abbott Monogenic Disease Testing Product Market Performance
  9.2.4 Abbott SWOT Analysis
  9.2.5 Abbott Business Overview
  9.2.6 Abbott Recent Developments
9.3 ELITech Group
  9.3.1 ELITech Group Basic Information
  9.3.2 ELITech Group Monogenic Disease Testing Product Overview
  9.3.3 ELITech Group Monogenic Disease Testing Product Market Performance
  9.3.4 ELITech Group SWOT Analysis
  9.3.5 ELITech Group Business Overview
  9.3.6 ELITech Group Recent Developments
9.4 Auto Genomics
  9.4.1 Auto Genomics Basic Information
  9.4.2 Auto Genomics Monogenic Disease Testing Product Overview
  9.4.3 Auto Genomics Monogenic Disease Testing Product Market Performance
  9.4.4 Auto Genomics Business Overview
  9.4.5 Auto Genomics Recent Developments
9.5 PerkinElmer
  9.5.1 PerkinElmer Basic Information
  9.5.2 PerkinElmer Monogenic Disease Testing Product Overview
  9.5.3 PerkinElmer Monogenic Disease Testing Product Market Performance
  9.5.4 PerkinElmer Business Overview
  9.5.5 PerkinElmer Recent Developments
9.6 Bio-Rad Laboratories
  9.6.1 Bio-Rad Laboratories Basic Information
  9.6.2 Bio-Rad Laboratories Monogenic Disease Testing Product Overview
  9.6.3 Bio-Rad Laboratories Monogenic Disease Testing Product Market Performance
  9.6.4 Bio-Rad Laboratories Business Overview
  9.6.5 Bio-Rad Laboratories Recent Developments

10 MONOGENIC DISEASE TESTING MARKET FORECAST BY REGION

10.1 Global Monogenic Disease Testing Market Size Forecast
10.2 Global Monogenic Disease Testing Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Monogenic Disease Testing Market Size Forecast by Country
  10.2.3 Asia Pacific Monogenic Disease Testing Market Size Forecast by Region
  10.2.4 South America Monogenic Disease Testing Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Sales of Monogenic Disease Testing by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

11.1 Global Monogenic Disease Testing Market Forecast by Type (2026-2035)
  11.1.1 Global Monogenic Disease Testing Market Size Forecast by Type (2026-2035)
11.2 Global Monogenic Disease Testing Market Forecast by Application (2026-2035)
  11.2.1 Global Monogenic Disease Testing Market Size (M USD) Forecast by Application (2026-2035)

12 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Monogenic Disease Testing Market Size by Type (M USD)
Table 4. Global Monogenic Disease Testing Market Size by Application
Table 5. Monogenic Disease Testing Market Size Comparison by Region (M USD)
Table 6. Global Monogenic Disease Testing Revenue (M USD) by Company (2020-2025)
Table 7. Global Monogenic Disease Testing Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Monogenic Disease Testing Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Monogenic Disease Testing Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Monogenic Disease Testing Market Size by Type (M USD)
Table 22. Global Monogenic Disease Testing Market Size (M USD) by Type (2020-2025)
Table 23. Global Monogenic Disease Testing Market Share by Type (2020-2025)
Table 24. Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
Table 25. Global Monogenic Disease Testing Market Size by Application
Table 26. Global Monogenic Disease Testing Market Size by Application (2020-2025) & (M USD)
Table 27. Global Monogenic Disease Testing Market Share by Application (2020-2025)
Table 28. Global Monogenic Disease Testing Market Size Growth Rate by Application (2021-2025)
Table 29. Global Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 30. Global Monogenic Disease Testing Market Size Market Share by Region (2020-2025)
Table 31. North America Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 34. South America Monogenic Disease Testing Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Monogenic Disease Testing Market Size by Region (2020-2025) & (M USD)
Table 36. Celera Support Services Basic Information
Table 37. Celera Support Services Monogenic Disease Testing Product Overview
Table 38. Celera Support Services Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Celera Support Services SWOT Analysis
Table 40. Celera Support Services Business Overview
Table 41. Celera Support Services Recent Developments
Table 42. Abbott Basic Information
Table 43. Abbott Monogenic Disease Testing Product Overview
Table 44. Abbott Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Abbott SWOT Analysis
Table 46. Abbott Business Overview
Table 47. Abbott Recent Developments
Table 48. ELITech Group Basic Information
Table 49. ELITech Group Monogenic Disease Testing Product Overview
Table 50. ELITech Group Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 51. ELITech Group SWOT Analysis
Table 52. ELITech Group Business Overview
Table 53. ELITech Group Recent Developments
Table 54. Auto Genomics Basic Information
Table 55. Auto Genomics Monogenic Disease Testing Product Overview
Table 56. Auto Genomics Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Auto Genomics Business Overview
Table 58. Auto Genomics Recent Developments
Table 59. PerkinElmer Basic Information
Table 60. PerkinElmer Monogenic Disease Testing Product Overview
Table 61. PerkinElmer Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 62. PerkinElmer Business Overview
Table 63. PerkinElmer Recent Developments
Table 64. Bio-Rad Laboratories Basic Information
Table 65. Bio-Rad Laboratories Monogenic Disease Testing Product Overview
Table 66. Bio-Rad Laboratories Monogenic Disease Testing Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Bio-Rad Laboratories Business Overview
Table 68. Bio-Rad Laboratories Recent Developments
Table 69. Global Monogenic Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 70. North America Monogenic Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 71. Europe Monogenic Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 72. Asia Pacific Monogenic Disease Testing Market Size Forecast by Region (2026-2035) & (M USD)
Table 73. South America Monogenic Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 74. Middle East and Africa Monogenic Disease Testing Market Size Forecast by Country (2026-2035) & (M USD)
Table 75. Global Monogenic Disease Testing Market Size Forecast by Type (2026-2035) & (M USD)
Table 76. Global Monogenic Disease Testing Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Industry Chain of Monogenic Disease Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monogenic Disease Testing Market Size (M USD), 2025-2035
Figure 5. Global Monogenic Disease Testing Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Monogenic Disease Testing Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Monogenic Disease Testing Product Life Cycle
Figure 12. Global Monogenic Disease Testing Revenue Share by Company in 2025
Figure 13. Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Monogenic Disease Testing Revenue in 2025
Figure 15. Value Chain Map of Monogenic Disease Testing
Figure 16. Global Monogenic Disease Testing Market PEST Analysis
Figure 17. Global Monogenic Disease Testing Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Monogenic Disease Testing Market Share by Type
Figure 20. Market Share of Monogenic Disease Testing by Type (2020-2025)
Figure 21. Global Monogenic Disease Testing Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monogenic Disease Testing Market Share by Application
Figure 24. Global Monogenic Disease Testing Market Share by Application (2020-2025)
Figure 25. Global Monogenic Disease Testing Market Share by Application in 2024
Figure 26. Global Monogenic Disease Testing Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Monogenic Disease Testing Market Size Market Share by Region (2020-2025)
Figure 28. North America Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Monogenic Disease Testing Market Size Market Share by Country in 2024
Figure 30. U.S. Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Monogenic Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Monogenic Disease Testing Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Monogenic Disease Testing Market Share by Country in 2024
Figure 35. Germany Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Monogenic Disease Testing Market Size Market Share by Region in 2024
Figure 42. China Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 48. South America Monogenic Disease Testing Market Size Market Share by Country in 2024
Figure 49. Brazil Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Monogenic Disease Testing Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Monogenic Disease Testing Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Monogenic Disease Testing Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Monogenic Disease Testing Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Monogenic Disease Testing Market Share Forecast by Type (2026-2035)
Figure 61. Global Monogenic Disease Testing Market Share Forecast by Application (2026-2035)